Richard Saynor has been CEO of Sandoz since July 15, 2019. He is a member of the Executive Committee of Novartis.
Mr. Saynor joined Novartis from GlaxoSmithKline (GSK) Pte. Ltd., where he most recently was senior vice president of classic and established products as well as commercial and digital platforms. During his nine years at GSK, he also served as senior vice president and global head of classic and established products; senior vice president and global head of established products; and senior vice president of classic brands and generics for Europe, Japan, and the emerging markets and Asia-Pacific (EMAP) region. From 2005 to 2010, Mr. Saynor held commercial operations leadership roles at Sandoz, serving as Region Head of all Asian markets and as Region Head of Asia-Pacific, Latin America, Canada and Turkey. He is a pharmacist by training and has also held positions at companies including Merck.
Mr. Saynor earned his Bachelor of Pharmacy from the University of Bradford in the United Kingdom. He is a member of the Royal Pharmaceutical Society in the UK, and served on the board of GSK India from 2018 to 2019.